WARS2
Basic information
Region (hg38): 1:119031216-119140654
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures (Strong), mode of inheritance: AR
- mitochondrial disease (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Parkinsonism-dystonia 3, childhood-onset | AR | Neurologic | The condition may include Parkinsonism features, and response to medical treatment (eg, with levodopa) has been described | Biochemical; Neurologic; Ophthalmologic | 28236339; 28650581; 28905505; 29120065; 31970218; 34890876 |
ClinVar
This is a list of variants' phenotypes submitted to
- Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures (2 variants)
- Inborn genetic diseases (1 variants)
- Parkinsonism-dystonia 3, childhood-onset (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the WARS2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 30 | 35 | ||||
missense | 54 | 69 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 11 | |||||
Total | 3 | 9 | 64 | 41 | 12 |
Variants in WARS2
This is a list of pathogenic ClinVar variants found in the WARS2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-119032674-C-G | Benign (May 17, 2021) | |||
1-119032915-A-G | Benign (Jan 23, 2024) | |||
1-119032921-CCCA-C | WARS2-related disorder | Uncertain significance (Jul 29, 2023) | ||
1-119032940-C-T | Inborn genetic diseases | Uncertain significance (Aug 15, 2023) | ||
1-119032958-C-T | Uncertain significance (Feb 08, 2024) | |||
1-119032964-C-A | Uncertain significance (Dec 11, 2019) | |||
1-119032978-G-A | Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures | Uncertain significance (Feb 22, 2019) | ||
1-119032979-A-T | Uncertain significance (Aug 08, 2022) | |||
1-119032981-C-G | Inborn genetic diseases | Uncertain significance (Dec 08, 2023) | ||
1-119032982-CA-C | Uncertain significance (Jan 19, 2022) | |||
1-119032984-A-G | Uncertain significance (Aug 02, 2022) | |||
1-119033006-G-A | Inborn genetic diseases | Uncertain significance (Mar 22, 2021) | ||
1-119033031-A-T | Likely benign (Apr 25, 2023) | |||
1-119033038-C-T | Uncertain significance (Dec 18, 2023) | |||
1-119033045-T-C | Uncertain significance (Jul 19, 2022) | |||
1-119033056-T-A | Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures • Inborn genetic diseases • WARS2-related disorder | Conflicting classifications of pathogenicity (Nov 17, 2023) | ||
1-119033064-C-T | WARS2-related disorder | Benign (Jan 29, 2024) | ||
1-119033069-C-A | Inborn genetic diseases | Uncertain significance (Dec 26, 2023) | ||
1-119033095-G-A | Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures | Uncertain significance (Nov 01, 2022) | ||
1-119033107-C-A | Uncertain significance (Jul 12, 2022) | |||
1-119033109-C-T | Likely benign (Jul 14, 2023) | |||
1-119033110-G-A | Uncertain significance (Jan 22, 2024) | |||
1-119033112-G-A | Likely benign (Aug 04, 2023) | |||
1-119033112-G-T | Parkinsonism-dystonia 3, childhood-onset | Uncertain significance (Dec 21, 2022) | ||
1-119033117-G-A | Inborn genetic diseases | Uncertain significance (May 04, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
WARS2 | protein_coding | protein_coding | ENST00000235521 | 6 | 109456 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0509 | 0.945 | 125713 | 0 | 35 | 125748 | 0.000139 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.902 | 174 | 211 | 0.825 | 0.0000125 | 2324 |
Missense in Polyphen | 58 | 85.851 | 0.67559 | 967 | ||
Synonymous | 0.691 | 79 | 87.2 | 0.906 | 0.00000559 | 733 |
Loss of Function | 2.52 | 5 | 15.8 | 0.317 | 8.44e-7 | 180 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000122 | 0.000122 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000601 | 0.000601 |
European (Non-Finnish) | 0.000142 | 0.000141 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Mitochondrial aminoacyl-tRNA synthetase that activate and transfer the amino acids to their corresponding tRNAs during the translation of mitochondrial genes and protein synthesis. {ECO:0000305|PubMed:28650581}.;
- Pathway
- Aminoacyl-tRNA biosynthesis - Homo sapiens (human);Tryptophan Metabolism;tRNA Aminoacylation;Translation;Metabolism of proteins;tRNA charging;Tryptophan metabolism;Tryptophan degradation;Mitochondrial tRNA aminoacylation
(Consensus)
Recessive Scores
- pRec
- 0.278
Intolerance Scores
- loftool
- 0.356
- rvis_EVS
- 0.24
- rvis_percentile_EVS
- 69.37
Haploinsufficiency Scores
- pHI
- 0.139
- hipred
- Y
- hipred_score
- 0.580
- ghis
- 0.490
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.570
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Wars2
- Phenotype
- hearing/vestibular/ear phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); muscle phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- wars2
- Affected structure
- trabecular layer
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- vasculogenesis;tRNA aminoacylation for protein translation;tryptophanyl-tRNA aminoacylation;mitochondrial tryptophanyl-tRNA aminoacylation
- Cellular component
- mitochondrion;mitochondrial matrix;plasma membrane
- Molecular function
- tryptophan-tRNA ligase activity;ATP binding